Chiasma Inc (CHMA) Sinks on FDA Speculation

Speculation is swirling that the Food and Drug Administration (FDA) will reject Chiasma Inc's (NASDAQ:CHMA) acromegaly treatment

Apr 14, 2016 at 2:58 PM
facebook twitter linkedin

It's a pretty mild day for the broader stock market, but biotech stock Chiasma Inc (NASDAQ:CHMA) is seeing some action. Specifically, the stock has plunged 13.8% to $9.40 -- after earlier being off by more than 17% -- on speculation the Food and Drug Administration (FDA) is preparing to reject Chiasma's oral treatment for acromegaly, a rare disease affecting the pituitary gland.

However, this negative price action is nothing new for Wall Street freshman CHMA, which is down 69% from its mid-August all-time high of $30.52. What's more, the stock's recent rally attempt was quickly halted by its 80-day moving average. CHMA has only closed north of this trendline twice since it was formed in mid-November.

Daily chart of CHMA

Short sellers, meanwhile, have been bracing for more downside. Short interest jumped 8.3% in the last two reporting periods, and now accounts for a lofty 12.5% of CHMA's available float. It would take almost a week to cover these shorted shares, at the stock's average daily pace of trading.

Analysts, however, have a taken a glass-half-full approach to CHMA. In fact, all four analysts covering the shares maintain a "strong buy" rating on the equity. Should Chiasma Inc (NASDAQ:CHMA) continue to struggle both on and off the charts, a round of downgrades could create more headwinds for the shares.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical  levels, and top economic stories straight to your inbox.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 


300x250 - Banner 3 - v1